The HealthSouth Corp. to Post Q4 2016 Earnings of $0.65 Per Share, SunTrust Banks Forecasts (HLS)

The HealthSouth Corp. to Post Q4 2016 Earnings of $0.65 Per Share, SunTrust Banks Forecasts (HLS)

HealthSouth Corp. (NYSE:HLS) – Stock analysts at SunTrust Banks lifted their Q4 2016 EPS estimates for HealthSouth Corp. in a report released on Friday. SunTrust Banks analyst D. Macdonald now forecasts that the brokerage will post earnings per share of $0.65 for the quarter, up from their previous estimate of $0.63. SunTrust Banks has a “Buy” rating and a $54.00 price objective on the stock. SunTrust Banks also issued estimates for HealthSouth Corp.’s Q2 2017 earnings at $0.71 EPS, Q3 2017 earnings at $0.67 EPS, Q4 2017 earnings at $0.72 EPS, FY2017 earnings at $2.78 EPS and FY2018 earnings at $3.06 EPS.

HealthSouth Corp. (NYSE:HLS) last posted its quarterly earnings data on Thursday, October 27th. The company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.05. HealthSouth Corp. had a net margin of 6.31% and a return on equity of 29.27%. The company earned $926.80 million during the quarter, compared to the consensus estimate of $448.60 million. During the same quarter in the prior year, the company posted $0.52 EPS. The company’s quarterly revenue was up 19.0% compared to the same quarter last year.

Several other research analysts have also recently issued reports on the company. Wells Fargo & Co. reissued a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 11th. JMP Securities reissued a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th. Finally, Zacks Investment Research cut HealthSouth Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. HealthSouth Corp. has an average rating of “Buy” and a consensus target price of $45.86.

HealthSouth Corp. (NYSE:HLS) opened at 39.67 on Monday. The stock’s 50 day moving average is $40.36 and its 200-day moving average is $40.23. The firm has a market cap of $3.53 billion, a P/E ratio of 16.43 and a beta of 1.02. HealthSouth Corp. has a 1-year low of $30.26 and a 1-year high of $43.38.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $0.96 annualized dividend and a yield of 2.42%. HealthSouth Corp.’s dividend payout ratio is currently 40.17%.

In related news, COO Mark J. Tarr sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, August 2nd. The stock was sold at an average price of $41.85, for a total transaction of $837,000.00. Following the completion of the transaction, the chief operating officer now owns 252,519 shares of the company’s stock, valued at $10,567,920.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 5.00% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in HLS. Creative Planning boosted its position in shares of HealthSouth Corp. by 2.0% in the second quarter. Creative Planning now owns 2,858 shares of the company’s stock valued at $111,000 after buying an additional 56 shares in the last quarter. Acrospire Investment Management LLC boosted its position in shares of HealthSouth Corp. by 32.1% in the second quarter. Acrospire Investment Management LLC now owns 3,700 shares of the company’s stock valued at $144,000 after buying an additional 900 shares in the last quarter. Societe Generale purchased a new position in shares of HealthSouth Corp. during the second quarter valued at $172,000. BNP Paribas Arbitrage SA boosted its position in shares of HealthSouth Corp. by 7,088.4% in the second quarter. BNP Paribas Arbitrage SA now owns 4,960 shares of the company’s stock valued at $193,000 after buying an additional 4,891 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in shares of HealthSouth Corp. by 438.6% in the second quarter. Tower Research Capital LLC TRC now owns 4,987 shares of the company’s stock valued at $194,000 after buying an additional 4,061 shares in the last quarter. 95.51% of the stock is owned by institutional investors and hedge funds.

HealthSouth Corp. Company Profile

Related posts

Leave a Comment